Pay in 4 interest-free payments of $7.07 Learn more
Ships within 48 hours · Estimated delivery Aug 13 - Aug 18
Neuroprotection and Neural Mechanisms GHK-Cu increases production of nerve growth factor and neurotrophins NT-3 and NT-4[15]
Immunogenicity associated with metreleptin treatment in patients with obesity or lipodystrophy
It is a combination of a GLP-1 agonist and an amylin agonist, explains Richard Siegel, MD, co-director of the Diabetes and Lipid Center at Tufts Medical Center and endocrinologist at Tufts Medicine Weight & Wellness Center Stoneham
If youre looking for other ways to support weight loss and are curious about peptides, the top options to consider are proven GLP-1 drugs, such as Ozempic or Wegovynot GHK-Cu
Less Common Events These appear sparsely in community data
In Novo Nordisk clinical trials it is being tested in combination with semaglutide (CagriSema) in Phase 3 obesity trials
